Mauripharm Limited - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 03120490 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2020

FOR

MAURIPHARM LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

A C Kureeman

REGISTERED OFFICE:

224 Barnett Wood Lane

Ashstead

Surrey

KT21 2DB

REGISTERED NUMBER:

03120490 (England and Wales)

ACCOUNTANTS:

Buckleys

Chartered Accountants

Unit 3, Shelley Farm

Shelley Lane

Ower

Romsey

Hampshire

SO51 6AS

FIXED ASSETS

Intangible assets

4

-

-

Tangible assets

5

553,215

570,198

Investments

6

7,863

7,863

561,078

578,061

CURRENT ASSETS

Stocks

91,925

91,925

Debtors

7

441,742

372,137

Cash at bank and in hand

74,539

6,661

608,206

470,723

CREDITORS

Amounts falling due within one year

8

449,870

350,644

NET CURRENT ASSETS

158,336

120,079

TOTAL ASSETS LESS CURRENT LIABILITIES

719,414

698,140

CREDITORS

Amounts falling due after more than one year

9

228,319

285,607

NET ASSETS

491,095

412,533

CAPITAL AND RESERVES

Called up share capital

200

200

Revaluation reserve

10

86,854

86,854

Retained earnings

404,041

325,479

SHAREHOLDERS' FUNDS

491,095

412,533

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2020.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2020 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 6 January 2021 and were signed by:

A C Kureeman - Director

1.	STATUTORY INFORMATION

Mauripharm Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 1998, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Land and buildings

-

2% on cost

Plant and machinery etc

-

25% on cost and 20% on reducing balance

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 14 (2019 - 10 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 April 2019

and 31 March 2020

136,000

AMORTISATION

At 1 April 2019

and 31 March 2020

136,000

NET BOOK VALUE

At 31 March 2020

-

At 31 March 2019

-

5.	TANGIBLE FIXED ASSETS

Plant and

Land and

machinery

buildings

etc

Totals

£

£

£

COST

At 1 April 2019

and 31 March 2020

684,969

132,796

817,765

DEPRECIATION

At 1 April 2019

131,197

116,370

247,567

Charge for year

13,698

3,285

16,983

At 31 March 2020

144,895

119,655

264,550

NET BOOK VALUE

At 31 March 2020

540,074

13,141

553,215

At 31 March 2019

553,772

16,426

570,198

6.	FIXED ASSET INVESTMENTS

Shares in

group

Other

undertakings

investments

Totals

£

£

£

COST

At 1 April 2019

and 31 March 2020

100

7,763

7,863

NET BOOK VALUE

At 31 March 2020

100

7,763

7,863

At 31 March 2019

100

7,763

7,863

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.20

31.3.19

£

£

Trade debtors

403,487

341,582

Other debtors

38,255

30,555

441,742

372,137

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.20

31.3.19

£

£

Bank loans and overdrafts

-

27,959

Trade creditors

360,400

285,980

Taxation and social security

29,146

26,622

Other creditors

60,324

10,083

449,870

350,644

9.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.3.20

31.3.19

£

£

Bank loans

228,319

285,607

Amounts falling due in more than five years:

Repayable by instalments

Bank loans more 5 yr by instal

228,319

285,607

10.

RESERVES

Revaluation

reserve

£

At 1 April 2019

and 31 March 2020

86,854

11.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2020 and 31 March 2019:

31.3.20

31.3.19

£

£

A C Kureeman

Balance outstanding at start of year

(894

)

3,374

Amounts advanced

69,118

98,525

Amounts repaid

(120,048

)

(102,793

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

(51,824

)

(894

)